
Strategic Commercial Executive with 15+ years of experience accelerating growth across the MEA pharmaceutical sector. Expert in full P&L ownership and leading high-impact teams to steer diverse portfolios—from Specialty Biological treatment and Branded Generics to mass-market Consumer Health. Adept at navigating complex regulatory landscapes to design and execute scalable strategies that secure sustainable advantage across the Kingdom and emerging markets.